C-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells

被引:0
|
作者
MacEwen, EG
Kutzke, J
Carew, J
Pastor, J
Schmidt, JA
Tsan, R
Thamm, DH
Radinsky, R
机构
[1] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA
[2] Univ Wisconsin, Ctr Comprehens Canc, Madison, WI USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
关键词
c-Met; canine; human; osteosarcoma; hepatocyte growth factor; invasion; molecular determinants; scatter factor; urokinase plasminogen activator;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To further characterize the role of hepatocyte growth factor-scatter factor (HGF-SF) and its receptor (c-Met) in osteosarcoma (OS), human OS cell lines with low (SAOS-2) and high (SAOS-LM2) metastatic potential, and cell lines derived from spontaneous canine OS were studied. All cell lines were evaluated for c-Met and HGF-SF expression and receptor activation using Northern, RT-PCR, and Western blot analyses, respectively. Functional activity of receptor-ligand interaction was measured using c-Met phosphorylation status, proliferation assays (anchorage-dependent and - independent), Matrigel invasion, modulation of urokinase plasminogen activator (uPA) expression, and cell dispersion ( scattering). All cell lines exhibited steady-state mRNA expression of c-Met. The canine OS cell lines also expressed HGF-SF mRNA as determined by RT-PCR analysis. Western analysis showed c-Met protein expression and HGF-stimulated ( human) or constitutive ( canine) receptor autophosphorylation. Treatment with recombinant human HGF resulted in enhanced proliferation in 3 of 5 OS cell lines and enhanced colony formation in 2 of 5 OS cell lines. Matrigel invasion was significantly enhanced in 3 of the cell lines and uPA levels were significantly increased in the SAOS-2 cells following HGF treatment. Scattering was enhanced in both the SAOS-2 and SAOS-LM2 cells. These data support the involvement of c-Met and HGF-SF in the growth and progression of human and canine OS, and may offer new targets for the development of therapeutic strategies for OS.
引用
收藏
页码:421 / 430
页数:10
相关论文
共 50 条
  • [21] Immunohistochemical expression of receptor tyrosine kinase PDGFR-α, c-Met, and EGFR in skull base chordoma
    R. Akhavan-Sigari
    M. Abili
    M. R. Gaab
    V. Rohde
    N. Zafar
    P. Emami
    H. Ostertag
    Neurosurgical Review, 2015, 38 : 89 - 99
  • [22] The Receptor Tyrosine Kinase, AXL, Regulates c-MET in Epithelial Ovarian Cancer
    Fuh, Katherine C.
    Rankin, Erinn B.
    Longacre, Teri
    Kariolis, Mihalis
    Cochran, Jennifer
    Giaccia, Amato
    REPRODUCTIVE SCIENCES, 2014, 21 (03) : 93A - 94A
  • [23] A selective inhibitor targeting c-Met receptor tyrosine kinase in gastric cancer
    Park, Byung Hee
    Yun, Sun-Mi
    Jung, Kyung Hee
    Lee, Hyunseung
    Hong, Soon-Sun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 350 - 350
  • [24] c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma
    Granito, Alessandro
    Guidetti, Elena
    Gramantieri, Laura
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2015, 2 : 29 - 38
  • [25] Oligomerization-induced differential dephosphorylation of c-Met receptor tyrosine kinase
    Sheth, PR
    Watowich, SJ
    BIOCHEMISTRY, 2005, 44 (33) : 10984 - 10993
  • [26] Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase
    Birchmeier, C
    Gherardi, E
    TRENDS IN CELL BIOLOGY, 1998, 8 (10) : 404 - 410
  • [27] Nuclear receptor tyrosine kinase c-MET restrains efficacy of PARP inhibitor in pancreatic cancer cells
    Gao, Yuan
    Chen, Mei-Kuang
    Yu, Dihua
    Hung, Mien-Chie
    CANCER RESEARCH, 2020, 80 (16)
  • [28] ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity
    Munshi, Neru
    Jeay, Sebastien
    Li, Youzhi
    Chen, Chang-Rung
    France, Dennis S.
    Ashwell, Mark A.
    Hill, Jason
    Moussa, Magdi M.
    Leggett, David S.
    Li, Chiang J.
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (06) : 1544 - 1553
  • [29] Expression and Prognostic Evaluation of the Receptor Tyrosine Kinase MET in Canine Malignant Melanoma
    Koo, Karen
    Wuenschmann, Arno
    Rendahl, Aaron
    Song, Kyu Young
    Forster, Colleen
    Wolf-Ringwall, Amber
    Borgatti, Antonella
    Giubellino, Alessio
    VETERINARY SCIENCES, 2023, 10 (04)
  • [30] Molecular imaging of c-Met tyrosine kinase activity
    Zhang, Limin
    Virani, Shama
    Zhang, Yu
    Bhojani, Mahaveer S.
    Burgess, Teresa L.
    Coxon, Angela
    Galban, Craig J.
    Ross, Brian D.
    Rehemtulla, Alnawaz
    ANALYTICAL BIOCHEMISTRY, 2011, 412 (01) : 1 - 8